Processing

Please wait...

Settings

Settings

Goto Application

1. WO1997026916 - OBESITY PROTEIN ANALOG COMPOUNDS AND FORMULATIONS THEREOF

Publication Number WO/1997/026916
Publication Date 31.07.1997
International Application No. PCT/US1997/001189
International Filing Date 24.01.1997
Chapter 2 Demand Filed 31.07.1997
IPC
A61K 38/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/575 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
575Hormones
CPC
A61K 38/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
C07K 14/5759
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
KPEPTIDES
14Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
435from animals; from humans
575Hormones
5759Products of obesity genes, e.g. leptin, obese (OB), tub, fat
Applicants
  • ELI LILLY AND COMPANY [US]/[US] (AllExceptUS)
  • HOFFMANN, James, A. [US]/[US] (UsOnly)
Inventors
  • HOFFMANN, James, A.
Agents
  • CALTRIDER, Steven, P.
Priority Data
60/011,05525.01.1996US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) OBESITY PROTEIN ANALOG COMPOUNDS AND FORMULATIONS THEREOF
(FR) COMPOSES D'ANALOGUES DE PROTEINES DE L'OBESITE ET PREPARATIONS A BASE DE CEUX-CI
Abstract
(EN)
The present invention provides novel compounds, which comprise an obesity protein analog complexed with a divalent metal cation, pharmaceutical formulations thereof, and methods of using such compounds for treating obesity, and disorders associated with obesity such as diabetes, cardiovascular disease and cancer.
(FR)
Nouveaux composés, constitués d'un analogue de protéine d'obésité soumis à complexion avec un cation métallique bivalent, préparations pharmaceutiques à base de ceux-ci et méthodes d'utilisation de ces composés pour le traitement de l'obésité et des troubles liés à l'obésité tels que le diabète, les maladies cardio-vasculaires et le cancer.
Latest bibliographic data on file with the International Bureau